Literature DB >> 13908335

Influence of coumarin treatment on plasma thromboplastin formation and heparin tolerance.

R HOLEMANS, M VERSTRAETE.   

Abstract

Entities:  

Keywords:  COUMARINS/therapy; HEPARIN/blood; THROMBOPLASTIN/pharmacology

Mesh：

Substances：

Year:  1962        PMID： 13908335     DOI： 10.1007/bf01570369

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  8 in total

1.  Plasma thromboplastin component (PTC) deficiency produced by prolonged administration or prothrombopenic anticoagulants.

Authors:  H S SISE; D M KIMBALL; D ADAMIS
Journal:  Proc Soc Exp Biol Med       Date:  1955-05

2.  The behaviour of coagulation factors during anticoagulant therapy with special reference to the one-stage test as an index of therapy.

Authors:  N D HICKS; J A BONNIN
Journal:  Br J Haematol       Date:  1959-04       Impact factor: 6.998

3.  [Methods of controlling the effect of anticoagulants].

Authors:  A LOELIGER
Journal:  Thromb Diath Haemorrh       Date:  1958-11-15

4.  [Present day status of coagulation research].

Authors:  F KOLLER
Journal:  Thromb Diath Haemorrh       Date:  1958-11-15

5.  Clotting factor X; physiologic and physico-chemical properties.

Authors:  F DUCKERT; P FLUCKIGER; M MATTER; F KOLLER
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

6.  Mode of action of coumarin drugs.

Authors:  A S DOUGLAS
Journal:  Br Med Bull       Date:  1955       Impact factor: 4.291

7.  The thromboplastin generation test.

Authors:  R BIGGS; A S DOUGLAS
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

8.  [Remarks on the technic and efficiency of heparin tolerance tests in vitro].

Authors:  K N VON KAULLA; W HENKEL
Journal:  Klin Wochenschr       Date:  1953-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.